top of page
Buscar


Radical supra maximal resection for newly diagnosed left-sided eloquent glioblastoma...
This is a very interesting study conducted by Di et al who evaluated the safety and effectiveness of the so-called radical supramaximal...

SNOLA
20 de jan. de 2023


ASTRO recently published the guideline for the management of patients with brain metastases...
ASTRO (American Society for Radiation Oncology) Guideline For Brain Metastases ASTRO recently published the guideline for the management...

SNOLA
20 de jan. de 2023


Cellular telephone use and the risk of brain tumors: Update of the UK Million Women Study...
Patients regularly question neuro-oncologists about a potential link between cellular telephones and the risk of developing a brain...

SNOLA
20 de jan. de 2023


Evaluation of effectiveness of different physical activities in patients with high grade glioma...
This trial conducted by the University of Basel evaluated the effectiveness of different physical activities in patients with high grade...

SNOLA
20 de jan. de 2023


An international multicenter matched cohort analysis of incidental meningioma progression during...
With this post, SNOLA starts an educational project that will include short reviews on relevant articles in the practice of...

SNOLA
2 de jun. de 2022


Highlights Society for Neuro-Oncology Latin America (SNOLA) 2022- THE STATE OF ART IN NEURO-ONCOLOGY
Society for Neuro-Oncology Latin America (SNOLA) organizou em 2022 um dos maiores eventos em neuro-oncologia da América Latina com...

SNOLA
22 de fev. de 2022


SNO 2020: Atezolizumab + Temozolomide and Radiation Shows Promise in Newly Diagnosed GBM
PD-1/PD-L1 inhibition may work synergistically with radiation. November 19, 2020—Houston, Texas—Atezolizumab + radiation and temozolomide...

SNOLA
10 de dez. de 2020


SNO 2020: TKIs Hold Promise in Oncogene-Driven NSCLC With Symptomatic CNS Metastases
The agents have demonstrated a remarkable intracranial activity. November 19, 2020—Houston, Texas—Upfront use of next generation tyrosine...

SNOLA
10 de dez. de 2020


SNO 2020: Larotrectinib Holds Promise in CNS Metastases of TRK Fusion Cancers
The drug was highly active and well tolerated in patients harboring such metastases. November 19, 2020—Houston, Texas—The tyrosine...

SNOLA
10 de dez. de 2020









SNOLA
12 de ago. de 2020



SNOLA
29 de jul. de 2020










bottom of page
.png)

